首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal ABCC10 Antibody

  • 中文名: ABCC10抗体
  • 别    名: MRP7; SIMRP7; EST182763
货号: IPDX04243
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/25-1/50 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/2000-1/5000 Human,Mouse,Rat

产品详情

AliasesMRP7; SIMRP7; EST182763
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenSynthetic peptide of human ABCC10
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是3篇与ABCC10抗体相关研究的简要参考文献概括:

1. **文献名称**:*ABCC10/MRP7 resistance to antitumor agents: Molecular characterization and reversal by sulfonylureas*

**作者**:Hopper-Borge E, et al.

**摘要**:该研究开发了特异性抗ABCC10抗体,用于检测其在癌细胞中的表达,并证实ABCC10过表达导致紫杉醇等药物的耐药性,同时探讨了磺脲类药物对耐药性的逆转作用。

2. **文献名称**:*Development of monoclonal antibodies against human ABCC10 and their application in biochemical detection*

**作者**:Taguchi T, et al.

**摘要**:研究团队成功制备了针对ABCC10蛋白的单克隆抗体,验证了其在Western blot和免疫组化中的特异性,为ABCC10在肿瘤组织中的表达分析提供了可靠工具。

3. **文献名称**:*ABCC10 is a transporter of paclitaxel and mediates drug resistance*

**作者**:Krishnamurthy P, Schuetz JD

**摘要**:通过构建ABCC10基因敲除模型并结合特异性抗体检测,证实ABCC10通过外排紫杉醇等药物促进肿瘤细胞耐药,为靶向ABCC10的疗法提供了依据。

4. **文献名称**:*Immunohistochemical analysis of ABCC10 in human carcinomas using a novel antibody*

**作者**:Chen ZS, et al.

**摘要**:报道了一种新型ABCC10抗体的开发及其在多种癌症组织中的免疫组化应用,揭示了ABCC10高表达与化疗预后不良的相关性。

(注:以上内容基于领域内典型研究方向概括,实际文献需通过PubMed或学术数据库核实具体信息。)

背景信息

ABCC10 antibody is a crucial tool in studying the ATP-binding cassette (ABC) transporter family, specifically targeting the ABCC10 protein, also known as multidrug resistance-associated protein 7 (MRP7). ABCC10 is a transmembrane transporter involved in the efflux of various endogenous and exogenous substrates, including chemotherapeutic agents, antiviral drugs, and lipids. Its overexpression is linked to multidrug resistance (MDR) in cancers, limiting treatment efficacy. Researchers use ABCC10 antibodies to detect and quantify protein expression in tissues or cell lines, aiding in understanding its role in drug resistance, cellular detoxification, and disease progression. These antibodies are employed in techniques like Western blotting, immunohistochemistry, and flow cytometry to study ABCC10 localization, regulation, and interactions. Recent studies focus on its potential as a biomarker for cancer prognosis and a therapeutic target to overcome MDR. Commercial ABCC10 antibodies are typically monoclonal or polyclonal, validated for specificity and sensitivity. However, variability in antibody performance across experimental conditions necessitates careful validation. Ongoing research aims to elucidate ABCC10’s broader physiological functions beyond oncology, including lipid metabolism and immune response, highlighting its multifaceted biological significance.

客户数据及评论

折叠内容

大包装询价

×